IFIH1 and dermatomyositis: We also found that the anti-MDA5 antibody levels were significantly higher in anti-MDA5 antibody-positive DM patients with RP-ILD than in those without RP-ILD (231.0 ± 55.6 versus 168.6 ± 79.7, P = 0.006).